A popular laboratory procedure for amplifying DNA and creating several copies of a targeted DNA region is called polymerase chain reaction (PCR). The main applications of PCR in medical and biological research include processing DNA for sequencing, identifying the presence or absence of a gene during infection, and creating forensic DNA profiles from minute DNA samples. For the identification and measurement of DNA and RNA sequences, molecular biologists use both Real-time PCR (qPCR) and Digital PCR (dPCR). During real-time PCR (qPCR), fluorescent probes are used to measure the amount of amplification product in real-time. It is commonly used for diagnosing genetic illnesses, finding bacterial and viral infections, and analysing gene expression. Rising diagnostic test demand, increasing prevalence of infectious illnesses, and expanding qPCR use in personalised medicine are driving the qPCR market. Digital PCR (dPCR), a more recent innovation, separates the PCR reaction into thousands of small droplets, each of which undergoes PCR amplification. The total amount of the starting substance is then determined by counting the positive droplets. Because dPCR offers greater sensitivity, specificity, and precision than qPCR, it is commonly employed for the detection of rare mutations, copy number variation investigations, and environmental DNA quantification. The demand for early cancer detection, genetic disease diagnosis, and environmental monitoring is fueling the growth of the dPCR market. Both the dPCR and qPCR markets are predicted to enjoy considerable growth due to the increased need for molecular diagnostics and genetic testing. Additionally, it is projected that the creation of unique and cutting-edge technologies in both markets, such as real-time PCR with melt curve analysis and digital droplet PCR, will further promote market expansion.
The COVID-19 pandemic has had a considerable effect on the real-time PCR (qPCR) and digital PCR (dPCR) markets. The demand for COVID-19 testing has raised demand for PCR technologies, particularly dPCR and qPCR. Now that these techniques are essential for detecting SARS-CoV-2 in patient samples, they play a significant role in the pandemic response. The market for dPCR and qPCR expanded significantly as labs, hospitals, and diagnostic centres boosted their testing capacity during the epidemic. Many biotech businesses have made large expenditures in the development of fresh PCR-based assays and technology to meet the rising demand for COVID-19 testing. The pandemic has, however, also led to challenges for the dPCR and qPCR market, including disruptions in the supply chain and shortages of reagents and other consumables. These challenges have increased the price of PCR-based tests and technologies, making some populations less able to adopt them. The COVID-19 pandemic has, overall, had a significant impact on the dPCR and qPCR businesses, offering both opportunities and challenges. It is anticipated that demand for PCR-based technologies will remain strong even after the epidemic has gone because they have demonstrated to be crucial in the detection and surveillance of infectious diseases.
Digital PCR (dPCR) and Real-time PCR (qPCR) Market Key Players:
The market study provides market data by competitive landscape, revenue analysis, market segments and detailed analysis of key market players such as; Abbott Laboratories, Agilent Technologies, Inc., Becton, Bio Rad Laboratories, Inc., Danaher Corporation, Dickinson Company, F. Hoffmann La Roche Ltd., Merck KGaA, Qiagen N.V., Takara Bio, Inc., Thermo Fisher Scientific, Inc.
Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Segmentation:
By Technology: Based on the Technology, Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market is segmented as; Digital PCR (dPCR), Quantitative PCR (qPCR).
By Product: Based on the Product, Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market is segmented as; Instruments, Reagents and Consumables, Software.
By Application: Based on the Application, Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market is segmented as; Clinical Applications (Blood Screening, Oncology Testing, Pathogen Testing, Other Clinical Applications), Forensic Applications, Research Applications.
By End-User: Based on the End-User, Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market is segmented as; Clinical Research Organizations, Forensic Laboratories, Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes.
By Region: The global market for digital PCR (dPCR) and real-time PCR (qPCR) is expanding. The market's greatest share is held by North America, followed by Europe and Asia-Pacific. The need for PCR-based technologies for research and diagnostics is a contributing factor in the expansion of these regions. The global market for PCR-based testing is expanding because to the rise of infectious diseases like COVID-19 and the growing demand for these tests.
This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report.